Fog Pharmaceuticals
PrivateLast Round
Private Placement
Jun 12, 2026
Est. Valuation
$2.3B
Total Funding Raised
$812M
Company Overview
Parabilis Medicines is a biopharmaceutical company that develops Helicon™ peptide therapeutics designed to target and neutralize historically undruggable intracellular cancer-causing proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fog Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Fog Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jun 12, 2026 | ||||
| IPO Announced | Jun 10, 2026 | ||||
| Series F | Jan 8, 2026 | ||||
| Series E | Mar 1, 2024 | ||||
| Series D | Nov 21, 2022 | ||||
Series C | Mar 1, 2021 |
Fog Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series F |
| Deerfield Management | Series C, Series A, Seed, Series B, Series D |
| Evercore ISI | IPO |
| Janus Henderson Group | Series F |
| Horizons Ventures | Series B |
| SymBiosis Capital Management | Series E |
| Boyu Capital | Seed, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2024
$145M round led by Nextech Invest.
- Nov 21, 2022
$178M round led by Farallon Capital Management and Fidelity.
Fog Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fog Pharmaceuticals's valuation, stock price, and market status.